CardioPhase® hsCRP

FDA 510(k) K212559 · Siemens Healthcare Diagnostics Products GmbH

Substantially Equivalent

510(k) numberK212559

Submission

Device name
CardioPhase® hsCRP
Applicant
Siemens Healthcare Diagnostics Products GmbH
Marburg, DE
Received
August 13, 2021
Decision date
December 16, 2022
Decision
Substantially Equivalent (SESE)
Type
Special 510(k)
Summary
510(k) summary available from FDA

Official FDA 510(k) record

Device classification

Product code
NQD – Cardiac C-Reactive Protein, Antigen, Antiserum, And Control
Device class
Class II (moderate risk)
Regulation
21 CFR 866.5270
Specialty
Immunology

In vitro diagnostic test to measure C-reactive protein for the purpose of making cardiac risk assessments.

Other 510(k)s with product code NQD

510(k)DeviceApplicantDecision
K260026Tina-quant Cardiac high sensitivity CRP IIINQD · Traditional Roche Diagnostics04/02/2026SE
K233242Atellica® CH High Sensitivity C-Reactive Protein 2 (hCRP2)NQD · Traditional Siemens Healthcare Diagnostics, Inc.01/18/2024SE
K173833CRP VarioNQD · Traditional SENTINEL CH. SpA09/27/2018SE
K081294Advia Chemistry Cardiophase High Sensitivity C-Reactive Protein (Hscrp), CalibratorsNQD · Traditional Siemens Healthcare Diagnostics, Inc.07/29/2008SE
K071002Immage Immunochemistry Systems High Sensitivity Cardiac C-Reactive Protein (CCRP) ReagentNQD · Traditional Beckman Coulter, Inc.06/21/2007SE
K070626Synchron Systems High Sensitivity Cardiac C-Reactive Protein (CRPH) ReagentNQD · Traditional Beckman Coulter, Inc.05/04/2007SE
K071017Immulite 2500 High Sensitivity C-Reactive Protein, Models L5KCRP (200 Tests), L5KCRP…NQD · Special Siemens Medical Solutions Diagnostics05/02/2007SE
K062924Stratus CS Acute Care Cardiophase Hscrp TestpakNQD · Traditional Dade Behring, Inc.12/26/2006SE
K063057Immulite/Immulite 1000, Immulite 2000 High Sensitivity CRPNQD · Abbreviated Diagnostic Products Corporation12/22/2006SE
K061802Dimension Vista Cardiophase Hscrp Flex Reagent Cartridge, Protein 2 Calibrator, Hscrp…NQD · Traditional Dade Behring, Inc.09/11/2006SE

More from Dade Behring, Inc.

510(k)DeviceDecision
K260331IMMULITE 2000 3gAllergy Specific IgE Vantage; IMMULITE 2000 Systems Peanut Allergen (F13)DHB · Traditional 09/04/2026SE
K240315INNOVANCE Anti-Xa (OPPU05); INNOVANCE Apixaban Standards (OPPW05); INNOVANCE Apixaban…QLU · Traditional 10/10/2024SE
K233946Immulite® 2000 Br-MaMOI · Traditional 03/13/2024SE
K233663N Antisera to Human Immunoglobulins (IgG, IgA, and IgM)CFN · Special 12/13/2023SE
K213510Immulite/Immulite 1000 Om-Ma, Immulite 2000 Om-MaLTK · Traditional 09/08/2023SE
K220728vWF AgGGP · Traditional 06/02/2023SE
K212379N Latex FLC kappa, N Latex FLC lambdaDFH · Traditional 03/02/2022SE
K201496N Latex FLC kappa, N Latex FLC lambdaDFH · Traditional 10/29/2021SE
K193047N Latex FLC kappa, N Latex FLC lambdaDFH · Traditional 07/14/2021SE
K203270IMMULITE/IMMULITE® 1000 CortisolCGR · Traditional 01/15/2021SE

Questions and answers

When was CardioPhase® hsCRP cleared by the FDA?

CardioPhase® hsCRP (K212559) received a 510(k) decision of Substantially Equivalent on December 16, 2022, 490 days after the submission was received.

What is the product code of K212559?

The FDA product code is NQD – Cardiac C-Reactive Protein, Antigen, Antiserum, And Control, a Class II (moderate risk) device regulated under 21 CFR 866.5270.